LONDON, July 2, 2018 /PRNewswire/ -- Forecasts for Trivalent Influenza Vaccines (TIV) & Quadrivalent Influenza Vaccines (QIV), Revenue Forecasts and Analysis of Pipeline Developments for Fluzone / VaxiGrip, Seqirus, Fluarix / FluLaval, FluMist / Fluenz, FluBlok and Other The...
from PR Newswire: //https://ift.tt/2ME7fuo
No comments:
Post a Comment